Department of Endocrinology & Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
J Neuroendocrinol. 2011 Apr;23(4):310-9. doi: 10.1111/j.1365-2826.2011.02116.x.
The biological function of thyrostimulin, consisting of the GPA2 and GPB5 subunit, is currently poorly understood. The recent observation that pro-inflammatory cytokines up-regulate the transcription of GPB5 in vitro suggested a role for thyrostimulin in the nonthyroidal illness syndrome, a state of altered thyroid hormone metabolism occurring during illness. In the present study, we used GPB5 knockout (GPB5(-/-) ) and wild-type (WT) mice to evaluate the role of GPB5 in the pituitary and hypothalamus during acute inflammation induced by lipopolysaccharide (LPS, bacterial endotoxin) administration. We evaluated serum thyroid hormones and mRNA expression of genes involved in thyroid hormone metabolism in the pituitary and in two hypothalamic regions; the periventricular region (PE) and the arcuate nucleus/median eminence region. As expected, LPS administration increased deiodinase type 2 mRNA in the PE, at the same time as decreasing pituitary thyrotrophin (TSH)β mRNA and serum thyroxine and triiodothyronine both in GPB5(-/-) and WT mice. GPB5 mRNA, but not GPA2 mRNA, markedly increased after LPS in the pituitary (200-fold) and hypothalamus of WT mice. In addition, we found large (>50%) suppression of TSH receptor (TSHR) mRNA in the pituitary and hypothalamus of WT mice but not in GPB5(-/-) mice. In conclusion, our results demonstrate in vivo regulation of central GPB5 transcription during acute illness. The observed differences between GPB5(-/-) and WT mice point to a distinct role for GPB5 in pituitary and hypothalamic TSHR suppression during acute illness.
促甲状腺激素释放激素的生物学功能,由 GPA2 和 GPB5 亚基组成,目前了解甚少。最近的观察表明,促炎细胞因子在体外上调 GPB5 的转录,这表明促甲状腺激素释放激素在非甲状腺疾病综合征中发挥作用,这是一种在疾病期间发生的甲状腺激素代谢改变的状态。在本研究中,我们使用 GPB5 敲除(GPB5(-/-))和野生型(WT)小鼠来评估 GPB5 在急性炎症期间在下丘脑和垂体中的作用,该急性炎症由脂多糖(LPS,细菌内毒素)给药引起。我们评估了血清甲状腺激素和涉及甲状腺激素代谢的基因在垂体和两个下丘脑区域中的 mRNA 表达;室周区(PE)和弓状核/正中隆起区。正如预期的那样,LPS 给药增加了 PE 中的脱碘酶 2 型 mRNA,同时降低了垂体促甲状腺素(TSH)β mRNA 和血清甲状腺素和三碘甲状腺原氨酸在 GPB5(-/-)和 WT 小鼠中。与 LPS 给药后 WT 小鼠的垂体和下丘脑相比,GPB5 mRNA(而非 GPA2 mRNA)明显增加(增加 200 倍)。此外,我们发现 WT 小鼠的垂体和下丘脑中的 TSH 受体(TSHR)mRNA 受到了>50%的抑制,但在 GPB5(-/-) 小鼠中没有。总之,我们的结果证明了在急性疾病期间中枢 GPB5 转录的体内调节。在 GPB5(-/-)和 WT 小鼠之间观察到的差异表明,GPB5 在急性疾病期间在下丘脑和垂体中 TSHR 抑制中发挥独特作用。